Fabio
5.8 KiB
type, title, description, jurisdiction, legislature, session, identifier, citation, classification, subjects, status, primary_sponsors, version_count, action_count, vote_count, first_action, last_action, source, source_identifier, source_url, source_hash, vintage, source_snapshot, retrieved_at, confidence, tags
| type | title | description | jurisdiction | legislature | session | identifier | citation | classification | subjects | status | primary_sponsors | version_count | action_count | vote_count | first_action | last_action | source | source_identifier | source_url | source_hash | vintage | source_snapshot | retrieved_at | confidence | tags | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bill | Schedule VI controlled substances and hypodermic syringes and needles; limited-use license. | Schedule VI controlled substances; hypodermic syringes and needles; limited-use license. Allows the Board of Pharmacy to issue a limited-use license for the purpose of dispensing Schedule VI controlled substances, excluding the combination of misoprostol and methotrexate, and hypodermic syringes and needles for the administration of prescribed controlled substances to a doctor of medicine, osteopathic medicine, or podiatry, a nurse practitioner, or a physician assistant, provided that such limited-use licensee is practicing at a nonprofit facility. The bill requires such nonprofit facilities to obtain a limited-use permit from the Board and comply with regulations for such a permit. This bill directs the Board of Pharmacy to adopt emergency regulations to implement the provisions of the bill. This bill is identical to HB 1654. | us/states/va | Virginia General Assembly | 2020 | SB 1074 | Virginia SB 1074 (2020) |
|
enacted |
|
4 | 29 | 6 | 2020-01-17 | 2020-04-02 | openstates | ocd-bill/d82da843-ce4c-40f5-aaec-df6e938619a6 | https://lis.virginia.gov/cgi-bin/legp604.exe?201+sum+SB1074 | 9c93cc2281784f618a9a26643929225b127be15d2fb4cb31eb94ffc240fed343 | 2026-07-01 | https://data.openstates.org/daily/2026-07-01/public.pgdump | 2026-07-06 | reported |
|
Virginia SB 1074 (2020) — Schedule VI controlled substances and hypodermic syringes and needles; limited-use license.
Schedule VI controlled substances; hypodermic syringes and needles; limited-use license. Allows the Board of Pharmacy to issue a limited-use license for the purpose of dispensing Schedule VI controlled substances, excluding the combination of misoprostol and methotrexate, and hypodermic syringes and needles for the administration of prescribed controlled substances to a doctor of medicine, osteopathic medicine, or podiatry, a nurse practitioner, or a physician assistant, provided that such limited-use licensee is practicing at a nonprofit facility. The bill requires such nonprofit facilities to obtain a limited-use permit from the Board and comply with regulations for such a permit. This bill directs the Board of Pharmacy to adopt emergency regulations to implement the provisions of the bill. This bill is identical to HB 1654.
Version chain
The bill's text revisions, in order — the diff chain from filing to enrollment.
- Acts of Assembly Chapter text (CHAP0610) (committee substitute) — source
- Bill text as passed Senate and House (SB1074ER) (committee substitute) — source
- Engrossed by Senate as amended SB1074E (committee substitute) — source
- Impact statement from DPB (SB1074) (committee substitute) — source
Votes
- Passed Senate (39-Y 0-N) — 39–0 (pass) · upper
- VOTE: Passage (96-Y 2-N) — 95–2 (pass) · lower
- Constitutional reading dispensed (37-Y 0-N) — 37–0 (pass) · upper
- Reported from Education and Health with amendment (15-Y 0-N) — 15–0 (pass) · upper
- Reported from Health, Welfare and Institutions (22-Y 0-N) — 22–0 (pass) · lower
- Constitutional reading dispensed (39-Y 0-N) — 39–0 (pass) · upper
Sponsors
- Jennifer L. McClellan — primary (person)
Timeline
The legislative action history — every referral, reading, and vote.
- 2020-01-17 Presented and ordered printed 20104584D
introduction - 2020-01-17 Referred to Committee on Education and Health
referral-committee - 2020-01-27 Assigned Education sub: Health Professions
referral-committee - 2020-01-28 Impact statement from DPB (SB1074)
- 2020-02-06 Reported from Education and Health with amendment (15-Y 0-N)
committee-passage - 2020-02-07 Constitutional reading dispensed (37-Y 0-N)
- 2020-02-10 Read second time
reading-2 - 2020-02-10 Reading of amendment waived
- 2020-02-10 Committee amendment agreed to
- 2020-02-10 Engrossed by Senate as amended SB1074E
- 2020-02-10 Constitutional reading dispensed (39-Y 0-N)
- 2020-02-10 Passed Senate (39-Y 0-N)
passage - 2020-02-10 Printed as engrossed 20104584D-E
- 2020-02-11 Impact statement from DPB (SB1074E)
- 2020-02-18 Placed on Calendar
- 2020-02-18 Read first time
reading-1 - 2020-02-18 Referred to Committee on Health, Welfare and Institutions
referral-committee - 2020-02-25 Reported from Health, Welfare and Institutions (22-Y 0-N)
committee-passage - 2020-02-27 Read second time
reading-2 - 2020-02-28 Read third time
reading-3 - 2020-02-28 Passed House (96-Y 2-N)
passage - 2020-02-28 VOTE: Passage (96-Y 2-N)
- 2020-03-05 Enrolled
- 2020-03-05 Impact statement from DPB (SB1074ER)
- 2020-03-06 Signed by Speaker
- 2020-03-07 Signed by President
- 2020-03-12 Enrolled Bill Communicated to Governor on March 12, 2020
- 2020-03-12 Governor's Action Deadline 11:59 p.m., April 11, 2020
- 2020-04-02 Approved by Governor-Chapter 610 (effective 7/1/20)
executive-signature
Source
OpenStates / OpenCivicData bulk snapshot 2026-07-01; origin ocd-bill/d82da843-ce4c-40f5-aaec-df6e938619a6. Confidence: reported (aggregated from official Virginia legislature records).